0001209191-18-051471.txt : 20180918 0001209191-18-051471.hdr.sgml : 20180918 20180918162748 ACCESSION NUMBER: 0001209191-18-051471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180917 FILED AS OF DATE: 20180918 DATE AS OF CHANGE: 20180918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Palczuk Linda CENTRAL INDEX KEY: 0001717580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38529 FILM NUMBER: 181075996 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660334 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463137900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 GARRETT STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-980-8100 MAIL ADDRESS: STREET 1: 200 GARRETT STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-17 0 0001660334 Verrica Pharmaceuticals Inc. VRCA 0001717580 Palczuk Linda C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380 0 1 0 0 Chief Operating Officer Common Stock 2018-09-17 4 P 0 2500 16.52 A 5500 D This transaction was executed in multiple trades at prices ranging from $16.52 to $16.55, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Consists of 3,000 shares of common stock held by Ms. Palczuk and 2,500 shares of common stock held by Ms. Palczuk jointly with her spouse. /s/ Mark Ballantyne, Attorney-in-Fact 2018-09-18